The DOI matches its OpenAlex record.
Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective
Abstract
Dermatologists routinely treat actinic keratoses (AKs) based on the belief that these lesions are premalignant and that treatment reduces morbidity. Marks et al1make a convincing case for conservative management by suggesting that malignant transformation of AKs is rare and that metastasis from such transformation is uncommon. They present their data as the relationship between AKs detected during an initial visit and squamous cell carcinoma (SCC) on examination 1 year later. Using this lesion-oriented approach, Marks and colleagues1,2have shown that the average malignant transformation rate for an actinic keratosis is only a fraction of a percent per year. Previous clinical estimates of malignant potential ranged as high as 25% and were based on patients with several AKs followed up for many years.3,4Historical estimates were thus more patient oriented. We will present a mathematical model resulting in patient-oriented statistics that can be more easily compared with
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Epidemiology of Skin Cancer
GLOSTER, H. M., & BRODLAND, D. G. (1996) · Dermatologic Surgery · doi:10.1111/j.1524-4725.1996.tb00312.x · Cited by 1,259
The epidemiology of skin cancer
Diepgen, T. L., & Mahler, V. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.146.s61.2.x · Cited by 1,100
Braathen, L. R., Szeimies, R.-M., Basset-Seguin, N., Bissonnette, R., Foley, P., Pariser, D., Roelandts, R., Wennberg, A.-M., & Morton, C. A. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.006 · Cited by 662
Epidemiology of actinic keratoses and squamous cell carcinoma
Salasche, S. J. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103342 · Cited by 531
The risk of progression to invasive disease
Glogau, R. G. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103339 · Cited by 484
Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches
Apalla, Z., Nashan, D., Weller, R. B., & Castellsagué, X. (2017) · Dermatology and Therapy · doi:10.1007/s13555-016-0165-y · Cited by 465
Criscione, V. D., Weinstock, M. A., Naylor, M. F., Luque, C., Eide, M. J., Bingham, S. F., & for the Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group (2009) · Cancer · doi:10.1002/cncr.24284 · Cited by 432
Histopathology of incipient intraepidermal squamous cell carcinoma (?actinic keratosis?)
Cockerell, C. J. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103344 · Cited by 333
Tsao, A. S., Kim, E. S., & Hong, W. K. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.3.150 · Cited by 331
Guidelines for the management of actinic keratoses
de Berker, D., McGregor, J. M., Hughes, B. R., & on behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07692.x · Cited by 296
Barton, J. K., Gossage, K. W., Xu, W., Ranger-Moore, J. R., Saboda, K., Brooks, C. A., Duckett, L. D., Salasche, S. J., Warneke, J. A., & Alberts, D. S. (2003) · Technology in Cancer Research & Treatment · doi:10.1177/153303460300200605 · Cited by 85
The actinic keratosis: A perspective and update
SCHWARTZ, R. A. (1997) · Dermatologic Surgery · doi:10.1111/j.1524-4725.1997.tb00438.x · Cited by 80
Ricotti, C., Bouzari, N., Agadi, A., & Cockerell, C. J. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.08.011 · Cited by 63
Metadata
- Authors
- Dodson, J. M.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association
- Published
- 1991-07-01
- Volume
- 127
- Issue
- 7
- Pages
- 1029-1031
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W4232205936
- Cited by
- 268
- References
- 0
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.